Alzheimers is a devastating diagnosis for people suffering from the disease, as well as their families, but a group of researchers feels that they are one step closer to finding a cure.
Alzheimer's disease (AD) affects about 5.7 million people in the US and is the leading cause of age-related dementia today. Many people suffering from AD face a myriad of challenges including the lack of effective treatments, reliable biomarkers, or preventive strategies. Unfortunately, several promising drug candidates in the past have failed in clinical trials so researchers are still searching for new preventions or therapies to combat the development of AD. But there seems to be hope with a new vaccine that may proceed to clinical trials after successful animal testing.
A new paper in the journal “Alzheimer's Research & Therapy” is opening the door for further research in 2020, with medical researchers at the Institute for Molecular Medicine and University of California, Irvine (UCI) working with a successful vaccine formulated on adjuvants(1) developed by Flinders University Professor Nikolai Petrovsky in South Australia.The causes of AD, in part, are believed to be tied to the role two proteins in the brain.